Skip to content
ClinCalc Pro
Menu
H1-antihistamine (theoclate salt)

Promethazine teoclate

Brand names: Avomine

Promethazine teoclate is a sedating, first-generation phenothiazine antihistamine used mainly to prevent and treat nausea and vomiting, including motion sickness.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It antagonises histamine H1 receptors and has central antimuscarinic and anti-emetic actions, dampening vestibular and chemoreceptor trigger zone input that drives nausea.

Prescribing in practice

  • It causes marked drowsiness and has antimuscarinic effects, so use cautiously in the elderly and avoid in those for whom sedation or anticholinergic burden is hazardous.
  • Avoid in patients with significant prostatic hypertrophy, urinary retention, narrow-angle glaucoma or pyloroduodenal obstruction owing to its antimuscarinic activity.
  • For motion sickness it is more effective taken before travel, and the teoclate salt is favoured for its longer duration of anti-emetic effect.

Monitoring

Routine monitoring is not generally needed, but assess for excessive sedation, anticholinergic effects and confusion, particularly in older patients.

Counselling the patient

  • Warn the patient that the medicine causes drowsiness and to avoid driving or operating machinery.
  • Advise avoiding alcohol while taking it.
  • For travel sickness, recommend taking it before the journey begins.

Evidence & guidelines

Promethazine teoclate is a well-established anti-emetic and antihistamine, with use for nausea and motion sickness supported by its SPC and long clinical experience.

Reference: RCOG GTG-69; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.